Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab‐naïve relapsed multiple myeloma. - Dima, Danai; Mansour, Razan; Davis, James A.; Minchak, Megan; Goel, Utkarsh; Atallah, Rawan; Logan, Emerson; Tabak, Carine; Rashid, Aliya; Ahmed, Nausheen; Abdallah, Al‐Ola; Hashmi, Hamza (European Journal of Haematology, 2024)